These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28803520)

  • 21. Spontaneous, Life-Threatening Hemorrhagic Cardiac Tamponade Secondary to Rivaroxaban.
    Kham NM; Song M
    Am J Ther; 2016; 23(4):e1128-31. PubMed ID: 26035030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of apixaban after development of suspected rivaroxaban-induced hepatic steatosis; a case report.
    Anastasia EJ; Rosenstein RS; Bergsman JA; Parra D
    Blood Coagul Fibrinolysis; 2015 Sep; 26(6):699-702. PubMed ID: 26154612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolongation of prothrombin time in the presence of rivaroxaban: is this the only cause?
    Sagheer S; McRae S
    Intern Med J; 2017 Feb; 47(2):225-227. PubMed ID: 28201865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation.
    Yoshimura A; Iriki Y; Ichiki H; Oketani N; Okui H; Maenosono R; Namino F; Miyata M; Ohishi M
    J Cardiol; 2017 Jan; 69(1):228-235. PubMed ID: 27131792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation.
    Noseworthy PA; Yao X; Abraham NS; Sangaralingham LR; McBane RD; Shah ND
    Chest; 2016 Dec; 150(6):1302-1312. PubMed ID: 27938741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of rivaroxaban anticoagulation by nonactivated prothrombin complex concentrate in urgent surgery.
    Chic Acevedo C; Velasco F; Herrera C
    Future Cardiol; 2015 Sep; 11(5):525-9. PubMed ID: 26090568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation.
    McCarty D; Robinson A
    Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):37-49. PubMed ID: 26378211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus.
    Peacock WF; Tamayo S; Sicignano N; Hopf KP; Yuan Z; Patel M
    Am J Cardiol; 2017 Mar; 119(5):753-759. PubMed ID: 28081941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous Hemopericardium in a Patient Receiving Apixaban Therapy: First Case Report.
    Sigawy C; Apter S; Vine J; Grossman E
    Pharmacotherapy; 2015 Jul; 35(7):e115-7. PubMed ID: 26095120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical usefulness of measuring prothrombin time and soluble fibrin levels in Japanese patients with atrial fibrillation receiving rivaroxaban.
    Nakano Y; Kondo T; Osanai H; Murase Y; Nakashima Y; Asano H; Ajioka M; Sakai K; Inden Y; Murohara T
    J Cardiol; 2015 Mar; 65(3):185-90. PubMed ID: 25192594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Piccini JP; Hellkamp AS; Washam JB; Becker RC; Breithardt G; Berkowitz SD; Halperin JL; Hankey GJ; Hacke W; Mahaffey KW; Nessel CC; Singer DE; Fox KA; Patel MR
    Circulation; 2016 Jan; 133(4):352-60. PubMed ID: 26673560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.
    Steppich B; Dobler F; Brendel LC; Hessling G; Braun SL; Steinsiek AL; Deisenhofer I; Hyseni A; Roest M; Ott I
    J Thromb Thrombolysis; 2017 May; 43(4):490-497. PubMed ID: 28316004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rash associated with dabigatran etexilate.
    To K; Reynolds C; Spinler SA
    Pharmacotherapy; 2013 Mar; 33(3):e23-7. PubMed ID: 23400964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers.
    Spiller HA; Mowry JB; Aleguas A; Griffith JR; Goetz R; Ryan ML; Bangh S; Klein-Schwartz W; Schaeffer S; Casavant MJ
    Ann Emerg Med; 2016 Feb; 67(2):189-95. PubMed ID: 26298448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHA
    Peacock WF; Tamayo S; Patel M; Sicignano N; Hopf KP; Yuan Z
    Ann Emerg Med; 2017 May; 69(5):541-550.e1. PubMed ID: 27913059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Repeated Cerebellar Hemorrhage Related to Rivaroxaban and Apixaban: A Case Report].
    Yokoi M; Toyama Y; Tsurusaki Y; Nakamura A; Mima Y; Kuwashiro T; Wakugawa Y; Yasaka M; Okada Y
    Brain Nerve; 2016 May; 68(5):573-7. PubMed ID: 27156511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Halperin JL; Hankey GJ; Wojdyla DM; Piccini JP; Lokhnygina Y; Patel MR; Breithardt G; Singer DE; Becker RC; Hacke W; Paolini JF; Nessel CC; Mahaffey KW; Califf RM; Fox KA;
    Circulation; 2014 Jul; 130(2):138-46. PubMed ID: 24895454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced thrombocytopenia after anticoagulation with rivaroxaban.
    Pop MK; Farokhi F; Iduna L
    Am J Emerg Med; 2018 Mar; 36(3):531.e1-531.e2. PubMed ID: 29306643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.